1xbet 보너스 코드 Pharmaceutical Co., Ltd.

1xbet 보너스 코드 Pharmaceutical Co., Ltd. hereby announces that a judgment was rendered on December 16, 2021 on an action seeking the revocation of a trial decision concerning the company's patent right for equol-containing foods (Patent Registration No. 6275313; Title of Invention: Equol-containing extract and method for producing the same, equol extraction method, and food containing equol; hereinafter the "Patent Right"). The judgment accepts the company's arguments and maintains the validity of the Patent Right.
1xbet 보너스 코드 will continue to vigorously defend and protect its inventions in relevant fields of technology, and provide safe and high-quality products and information to support people's health based on scientific evidence.

1xbet 보너스 코드 Pharmaceutical Foods Containing Equol

EQUELLE was launched in April 1xbet 보너스 코드 2014 as the supplement containing equol, made by fermenting a soy is1xbet 보너스 코드lavone component with lactic acid bacterium. The product was initially sold as a basic supplement to support the health and beauty 1xbet 보너스 코드 women aged 40 and over. The EQUELLE product line has since been expanded by the addition 1xbet 보너스 코드 equol-containing Equelle Gelée and tocoelle, products developed to support women during different life-stage transitions.

* Court

1xbet 보너스 코드tellectual Property High Court

Case number

2020 (Gyo-Ke) #10150

Case name

Appeal proceedings to decision 1xbet 보너스 코드 Japan Patent 1xbet 보너스 코드fice

Pla1xbet 보너스 코드tiff

Daicel Corporation

Additional pla1xbet 보너스 코드tiff

Advanced Medical Care 1xbet 보너스 코드c.

Defendant

1xbet 보너스 코드 Pharmaceutical Co., Ltd.